Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...

Draganfly Announces Agreement to Pilot Drone Delivery Services Program for Mass General Brigham’s Home Hospital Just-in-time medical drone deliveries by Draganfly to include critical medicines, technical equipment, and laboratory work to benefit patient care. Boston, MA., Jan. 16, 2024 (GLOBE NEWSWIRE)...

Coming Soon to a Clinic Near You: Top 12 Emerging Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham Boston, MA, June 14, 2023 (GLOBE NEWSWIRE) -- Mass General Brigham today revealed the annual “Disruptive Dozen,” 12 emerging technologies with the greatest potential to impact health care in the...

IMUNON CEO to Discuss Company’s Novel Non-viral DNA Therapy Option at the Mass General Brigham World Medical Innovation Forum 2023 Dr. Corinne Le Goff will highlight the breakthrough potential of IMNN-001 for the treatment of ovarian cancer during a panel discussion LAWRENCEVILLE, N.J., June 12, 2023 (GLOBE NEWSWIRE) --...

Mass General Brigham launches community health vans Boston, MA, Jan. 27, 2021 (GLOBE NEWSWIRE) -- To better support the people who live and work in communities hardest hit by COVID-19, Mass General Brigham is launching a fleet of community health...